Rock-Springs-Capital-Management-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
96
Total Value
1747790415
Accession Number
0001172661-25-001953
Form Type
13F-HR
Manager Name
Rock-Springs-Capital-Management-Lp
Data Enrichment
94% identified
90 identified6 unidentified

Holdings

96 positions
Manager:
Search and click to pin securities to the top
Page 5 of 5
BIOCRYST PHARMACEUTICALS INC
Shares:222.0K
Value:$1.7M
MACROGENICS INC
Shares:1.1M
Value:$1.5M
COMPUGEN LTD
Shares:990.0K
Value:$1.4M
Mersana Therapeutics, Inc.
Shares:3.8M
Value:$1.3M
Neurogene Inc.
Shares:104.3K
Value:$1.2M
Amylyx Pharmaceuticals, Inc.
Shares:343.2K
Value:$1.2M
829401108
Shares:99.4K
Value:$1.0M
Applied Therapeutics, Inc.
Shares:2.1M
Value:$1.0M
Perspective Therapeutics, Inc.
Shares:444.4K
Value:$946.5K
Vigil Neuroscience, Inc.
Shares:472.0K
Value:$840.1K
PLIANT THERAPEUTICS, INC.
Shares:590.0K
Value:$796.5K
SPRUCE BIOSCIENCES, INC.
Shares:2.6M
Value:$756.9K
Korro Bio, Inc.
Shares:35.7K
Value:$621.9K
Adaptimmune Therapeutics PLC
Shares:2.5M
Value:$489.2K
00444T209
Shares:316.5K
Value:$156.6K
67080N119
Shares:134.0K
Value:$32.0K